Page last updated: 2024-08-23

alovudine and Necrosis

alovudine has been researched along with Necrosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horky, LL; Treves, ST	1
Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B	1
Boucher, KM; Butterfield, RI; Christian, PE; Enslow, MS; Heilbrun, ME; Hoffman, JM; Jensen, RL; Kadrmas, DJ; Morton, KA; Zollinger, LV	1

Reviews

1 review(s) available for alovudine and Necrosis

Article	Year
PET and SPECT in brain tumors and epilepsy. Neurosurgery clinics of North America, 2011, Volume: 22, Issue:2 Topics: Brain; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Epilepsy; Flumazenil; Fluorodeoxyglucose F18; GABA Modulators; Humans; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2011

Trials

1 trial(s) available for alovudine and Necrosis

Article	Year
Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Clinical nuclear medicine, 2012, Volume: 37, Issue:9 Topics: Adult; Aged; Diagnosis, Differential; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Recurrence; Young Adult	2012

Article

Year

Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.

Clinical nuclear medicine, 2012, Volume: 37, Issue:9

Topics: Adult; Aged; Diagnosis, Differential; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Recurrence; Young Adult

2012

Other Studies

1 other study(ies) available for alovudine and Necrosis

Article	Year
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:8 Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment	2012

Article

Year

Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:8

Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment

2012